Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.420
0.00 (0.00%)
Apr 1, 2025, 4:00 PM EDT - Market closed
Cocrystal Pharma Market Cap
Cocrystal Pharma has a market cap or net worth of $14.45 million as of April 1, 2025. Its market cap has decreased by -3.04% in one year.
Market Cap
14.45M
Enterprise Value
6.39M
1-Year Change
-3.04%
Ranking
Category
Stock Price
$1.42
Market Cap Chart
Since March 12, 2018, Cocrystal Pharma's market cap has decreased from $115.30M to $14.45M, a decrease of -87.47%. That is a compound annual growth rate of -25.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 14.40M | -30.10% |
| Dec 31, 2024 | 20.60M | 17.71% |
| Dec 29, 2023 | 17.50M | 10.06% |
| Dec 30, 2022 | 15.90M | -74.92% |
| Dec 31, 2021 | 63.40M | -31.97% |
| Dec 31, 2020 | 93.20M | 435.63% |
| Dec 31, 2019 | 17.40M | -83.84% |
| Dec 31, 2018 | 107.70M | -6.59% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.31B |
| UnitedHealth Group | 480.21B |
| Johnson & Johnson | 400.32B |
| AbbVie | 366.98B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 229.45B |
| AstraZeneca | 229.16B |
| Merck & Co. | 225.45B |